who should not take glp-1 receptor agonists Benefits and Risks of Outlined Your guide to GLP-1 side

After 6 months, patients taking Tesamorelin showed an 18% reduction in visceral fat (about 21 cm) on average compared to almost no reduction in the placebo group

Achieving sustainable weight loss requires a comprehensive approach that includes dietary adjustments, physical activity, behavior modifications, and, in some cases, medical intervention

The remodeling of T-tubules destroys accurate communication between L-type voltage-gated Ca 2+ channels (VGCCs), located predominantly on the T-tubule membrane, and type 2 ryanodine receptor (RyR2), a Ca 2+ -release channel located on the sarcoplasmic reticulum (108)

Neonatal respiratory distress syndrome: an inflammatory disease

was supported by the Alexander von Humboldt fellowship

References Evans AM, Fornasini G